SCHEMBL3395044

SCHEMBL3395044

Cc1c(C2=CCCCC2)[nH]c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.46
MAPT P10636 6/20 0.43
ALDH1A1 P00352 6/20 0.43
LMNA P02545 5/20 0.43
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
ELANE P08246 1/20 0.40
KDM4E B2RXH2 5/20 0.40
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR6 P50406 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 2/20 0.40
ADRB2 P07550 1/20 0.40
HTR1A P08908 1/20 0.40
HTR7 P34969 1/20 0.40
HTR5A P47898 1/20 0.40
NISCH Q9Y2I1 1/20 0.40
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14448753 0.79 HTR6 (0.62) AHRMAPTALDH1A1LMNAKDM4E
SCHEMBL29033503 0.75 HTR2A (0.63) MAPTALDH1A1ELANEKDM4EHTR2A
SCHEMBL7195762 0.74 AHR (0.70) AHRMAPTALDH1A1LMNACYP11B1
SCHEMBL29222469 0.71 KIF11 (0.47) ELANEKIF11
SCHEMBL736103 0.70 OPRM1 (0.49) AHRMAPTHTR2AMEN1KMT2A
SCHEMBL6296691 0.69 DRD2 (0.60) MAPTALDH1A1LMNAKDM4EHTR2A
SCHEMBL5332251 0.69 KDM4E (0.57) MAPTALDH1A1LMNAELANEKDM4E
SCHEMBL24074534 0.69 KDM4E (0.51) MAPTALDH1A1KDM4EHTR6HTR1A
SCHEMBL1260425 0.67 CYP11B1 (0.66) AHRMAPTALDH1A1CYP11B1CYP11B2
Ethylene SCHEMBL7481976 0.67 DRD2 (0.57) MAPTALDH1A1LMNAKDM4EHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066324-B1 CYCLOALKANOPYROLOCARBAZOLE DERIVATIVES AND THE USE THEREOF AS PARP, VEGFR2 AND MLK3 INHIBITORS CEPHALON INC (US) 2013-05-29 EP disclosed
EP-2050750-B1 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes CEPHALON INC (US) 2010-09-22 EP disclosed
EP-2066324-A2 CYCLOALKANOPYROLOCARBAZOLE DERIVATIVES AND THE USE THEREOF AS PARP, VEGFR2 AND MLK3 INHIBITORS CEPHALON, INC. (US) 2009-06-10 EP disclosed
WO-2007149451-A2 CYCLOALKANOPYRROLOCARBAZOLE DERIVATIVES AND THE USE THEREOF AS PARP, VEGFR2 AND MLK3 INHIBITORS CEPHALON, INC. (US) 2007-12-27 WO disclosed
EP-1294725-A2 MULTICYCLIC COMPOUNDS AND THE USE THEREOF AS INHIBITORS OF PARP, VEGFR2 AND MLK3 ENZYMES CEPHALON, INC. (US) 2003-03-26 EP disclosed
WO-2001085686-A2 MULTICYCLIC COMPOUNDS AND THE USE AS INHIBITORS OF PARP, VEGFR2 AND MLK3 ENZYMES CEPHALON, INC. (US) 2001-11-15 WO disclosed